Ledger.Open graph →

SEC Form D · Amendment · filed January 9, 2014

AETHLON MEDICAL INC

Offering

$2.0M

Sold

$1.8M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN DIEGO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Max Volsky · New York, NYExec · Director Arun K. Pandey · Birmingham, ALExec · Director Daniel Grams · Upland, NEDirector Brent Rivard · SAN DIEGO, CADirector David R. Vickerman · Nashville, TNExec · Director Richard H. Tullis, Ph.D · SAN DIEGO, CAExec · Director Leonard Kleinrock · Beverly Hills, CADirector Gia-Shuh Jang · Cupertino, CAExec · Director Franklyn S. Barry, Jr · SAN DIEGO, CADirector Ansel P. Clark · Waycross, GAExec · Director James B. Frakes · SAN DIEGO, CAExec Thomas S. Wornham · SAN DIEGO, CADirector Edward G. Broenniman · SAN DIEGO, CADirector William P. Langdale, Iii · Waycross, GAExec James A. Joyce · SAN DIEGO, CAExec · Director Rodney S. Kenley · SAN DIEGO, CAExec · Director Phillip S. Ward · SAN DIEGO, CADirector Philip N. Bredesen · Nashville, TNDirector Chetan S. Shah, Md · SAN DIEGO, CADirector Shioupyn Shen · Saratoga, CAExec · Director William J. Monroe, Jr · Waycross, GADirector Scot Eisendrath · SAN DIEGO, CADirector Jeff N. Mouland · Nashville, TNDirector Seth Harder · Plainview, NEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗